HAEMONETICS CORP — Director's Dealing 2015

Apr 14, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2015-04-13

Reporting Person: Helsel Dave (EVP, Global Manufacturing)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-13	Common Stock	D	302.0	$43.7281	Disposed	13216	Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.